EUVIMEDEUVIMED entdecken
Open Access

CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells

Phillip Schiele iD, Alberto Sada Japp iD, Regina Stark iD, Joanna J Sattelberg, Christos Nikolaou iD, Gereon Kornhuber iD, Parya Abbasi iD, Nina Ding iD, Stanislav Rosnev iD, Stefan Meinke iD, Kerstin Mühle, Lucie Loyal iD und 14 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adr9331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Phillip Schiele und 25 weiteren Autor:innen. Beteiligte Einrichtung: Therapy-Induced Remodeling in Immuno-Oncology, BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizi…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, CD40 Ligand, CD40 Antigens, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cells and their effector functions, in particular the canonical cytotoxicity of CD8 + T cells involving perforin, granzymes, Fas ligand (FasL), and tumor necrosis factor related apoptosis inducing ligand (TRAIL), are crucial for tumor immunity. Here, we reveal a previously unidentified mechanism by which CD40L-expressing CD8 + T cells induce cytotoxicity in cancer cells. In murine models, up to 50% of tumor-specific CD8 + T cells expressed CD40L, and conditional CD40L ablation in CD8 + T cells alone led to tumor formation. Mechanistically, CD40L + CD8 + T cells can induce cell death in CD40-expressing cancer cells by triggering caspase-8 activation. We demonstrate that a gene signature for resistance to CD40 signaling–induced cell death strongly correlates with worse survival in different human cancer cohorts. Our results introduce CD40L as a rather counterintuitive, noncanonical cytotoxic factor that complements the capabilities of CD8 + T cells to combat cancers and has the potential to enhance the efficacy of immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesCD40 LigandCD40 AntigensNeoplasmsCytotoxicity, ImmunologicAnimalsHumansMiceCell Line, TumorSignal TransductionCaspase 8

Substanzen

CD40 LigandCD40 AntigensCaspase 8

Autor:innen und Institutionen

  • Therapy-Induced Remodeling in Immuno-Oncology, BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Regenerative Immunology and Aging, BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Captain T Cell GmbH, 12529 Berlin, Germany.
  • Tissue Immunology, BIH Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Max-Delbrück-Center for Molecular Medicine and Institute for Immunology, Charité-Universitätsmedizin Berlin, 13125 Berlin, Germany.
  • Si-M/"Der Simulierte Mensch," Technische Universität Berlin and Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany.

ORCID-Profile: Phillip Schiele, Alberto Sada Japp, Regina Stark, Christos Nikolaou, Gereon Kornhuber, Parya Abbasi, Nina Ding, Stanislav Rosnev, Stefan Meinke, Lucie Loyal, Julian Braun, Manuela Dingeldey, Slawomir Wolczynski, Nafis A Rahman, Ichiro Taniuchi, Stephan Schlickeiser, Claudia Giesecke-Thiel, Il-Kang Na, Andreas Thiel, Marco Frentsch

Zitieren

APA

Schiele, P., Japp, A. S., Stark, R., Sattelberg, J. J., Nikolaou, C., Kornhuber, G., Abbasi, P., Ding, N., Rosnev, S., Meinke, S., Mühle, K., Loyal, L., Braun, J., Dingeldey, M., Durlanik, S., Matzmohr, N., Ponikwicka-Tyszko, D., Wolczynski, S., Rahman, N. A., …, & Frentsch, M. (2025). CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells. Science Advances. https://doi.org/10.1126/sciadv.adr9331

Vancouver

Schiele P, Japp AS, Stark R, Sattelberg JJ, Nikolaou C, Kornhuber G, et al. CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells. Science Advances. 2025. doi:10.1126/sciadv.adr9331

BibTeX
@article{Schiele2025,
  author = {Schiele, Phillip and Japp, Alberto Sada and Stark, Regina and Sattelberg, Joanna J and Nikolaou, Christos and Kornhuber, Gereon and Abbasi, Parya and Ding, Nina and Rosnev, Stanislav and Meinke, Stefan and Mühle, Kerstin and Loyal, Lucie and Braun, Julian and Dingeldey, Manuela and Durlanik, Sibel and Matzmohr, Nadine and Ponikwicka-Tyszko, Donata and Wolczynski, Slawomir and Rahman, Nafis A and Taniuchi, Ichiro and Schlickeiser, Stephan and Giesecke-Thiel, Claudia and Blankenstein, Thomas and Na, Il-Kang and Thiel, Andreas and Frentsch, Marco},
  title = {CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adr9331}
}
Kostenlos starten →